CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
Authors
Keywords
-
Journal
PROSTATE
Volume 75, Issue 12, Pages 1227-1246
Publisher
Wiley
Online
2015-06-13
DOI
10.1002/pros.23007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
- (2015) Urszula M. Domanska et al. NEOPLASIA
- XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
- (2014) Giovanni Gravina et al. Journal of Hematology & Oncology
- Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
- (2014) Donald Wong et al. BMC Urology
- Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion
- (2013) Shengqiang Yu et al. MEDICAL ONCOLOGY
- Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc
- (2013) K. Hatano et al. MOLECULAR CANCER RESEARCH
- A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
- (2012) G. L. Uy et al. BLOOD
- Thromboxane A2 receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells
- (2012) Yoshio Matsui et al. CANCER SCIENCE
- Pathological roles of invadopodia in cancer invasion and metastasis
- (2012) Hideki Yamaguchi EUROPEAN JOURNAL OF CELL BIOLOGY
- Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells
- (2012) Julia Schulte et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer
- (2012) Astrid Drenckhan et al. JOURNAL OF SURGICAL RESEARCH
- The role of IL-8 in the SDF-1α/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma
- (2012) Kai-Chun Li et al. ORAL ONCOLOGY
- Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer
- (2012) Stephanie J. Gros et al. PLoS One
- Occupy tissue
- (2012) Peta Bradbury et al. Cell Adhesion & Migration
- Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line
- (2011) Qinwen Wang et al. CELL BIOLOGY INTERNATIONAL
- Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer
- (2011) R. Larsson et al. CURRENT MEDICINAL CHEMISTRY
- CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
- (2011) S. Liekens et al. CURRENT PHARMACEUTICAL DESIGN
- The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells
- (2011) G. L. Gravina et al. ENDOCRINE-RELATED CANCER
- RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways
- (2011) Yukuan Feng et al. EUROPEAN JOURNAL OF CANCER
- The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling
- (2011) Yi-fang Ping et al. JOURNAL OF PATHOLOGY
- CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma
- (2011) Bao-Cheng Zhao WORLD JOURNAL OF GASTROENTEROLOGY
- p53 Status in Stromal Fibroblasts Modulates Tumor Growth in an SDF1-Dependent Manner
- (2010) Y. Addadi et al. CANCER RESEARCH
- Estimates of cancer incidence and mortality in Europe in 2008
- (2010) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases
- (2010) Daisuke Uchida et al. EUROPEAN JOURNAL OF CANCER
- Effects of transplantation of adipose tissue-derived stem cells on prostate tumor
- (2010) Guiting Lin et al. PROSTATE
- PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression
- (2009) Y Lee et al. ONCOGENE
- Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth
- (2009) Stacy Porvasnik et al. PROSTATE
- Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100
- (2008) B. Nervi et al. BLOOD
- Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer
- (2008) Takuya Akashi et al. CANCER SCIENCE
- A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
- (2008) Eugene H. Huang et al. JOURNAL OF SURGICAL RESEARCH
- CXCL12/CXCR4 Transactivates HER2 in Lipid Rafts of Prostate Cancer Cells and Promotes Growth of Metastatic Deposits in Bone
- (2008) S. R. Chinni et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More